Galderma India has promoted Ashish Ghosh to Business Unit Head, Therapeutic Dermatology (TD), strengthening its leadership bench. The move supports the company’s strategy to scale its prescription-led dermatology business across India.
Driving prescription dermatology growth
Galderma’s Therapeutic Dermatology division drives its prescription portfolio, advancing evidence-based dermatological solutions through strong engagement with healthcare practitioners. The appointment aligns with Galderma’s accelerated growth in India and its focus on strengthening leadership in prescription dermatology.
Ghosh brings over a decade of experience, having begun his Galderma career in a front-line role. He steadily assumed greater sales and marketing responsibilities, building strong on-ground and commercial expertise in therapeutic dermatology. His progression reflects Galderma’s commitment to nurturing internal talent and creating leadership pathways from within the organisation.
Future focus and mandate
Under his tenure, the Therapeutic Dermatology business delivered consistent growth, blockbuster performance, and strengthened Galderma’s prescription dermatology leadership. Under his sales and marketing leadership, the division enhanced HCP engagement, expanded portfolio adoption, and maintained strong momentum across key areas.
In his new role as Business Unit Head, Ghosh will focus on accelerating growth while strengthening market leadership across Galderma’s dermatology portfolio. His mandate will include driving strategic execution, deepening HCP partnerships, and supporting the company’s long-term vision.
Ashish Ghosh said his roles across different cities and challenges shaped him professionally and personally. He added that Galderma’s environment, which encourages freedom, ownership, and leadership, drove his development.
Commitment to innovation and growth
Galderma continues to expand its footprint in India by investing in leadership depth, innovation-led growth, and a strong prescription-focused strategy. The company remains committed to developing differentiated dermatology solutions while empowering its teams to drive long-term value across its portfolio.
Galderma continues to focus on strengthening its leadership, expanding its presence, and delivering innovative dermatology solutions. The company remains dedicated to supporting healthcare practitioners, enhancing patient care, and driving sustainable growth across its prescription and therapeutic dermatology portfolio in India.